期刊文献+

甲襞微循环综合定量法评价前列腺素E_1对老年下肢动脉硬化闭塞症的临床疗效 被引量:1

Evaluation of clinical effects with capillaroscopy in aged patients with low extremity atherosclerosis disease treated by Prostaglandin E_(1)
下载PDF
导出
摘要 目的:探讨甲襞微循环综合定量法对于评价前列腺素E1对老年下肢动脉硬化闭塞症患者疗效的临床应用价值。方法:对48例老年下肢动脉硬化闭塞症患者于治疗前及前列腺素E1脂微球载体制剂(Lipo-PGE1)治疗后应用甲襞微循环综合定量法进行微循环观测并作比较。结果:治疗后甲襞微循环总积分值显著降低(P<0.01),各分类积分值均降低(P<0.05),同时甲襞微循环总积分值与踝肱指数存在直线负相关(P<0.01)。结论:甲襞微循环综合定量法对于前列腺素E1治疗老年下肢动脉硬化闭塞症患者的疗效判断具有较高的临床实用价值。 Objective:To investigate the value of nail fold microcirculation in evaluating clinical effects after Lipo-PGE_(1) treatment in aged patients with low extremity atherosclerosis disease (LEASD). Methods:48 male aged LEASD patients were selected from inpatient of the PLA General Hospital and treated by Lipo-PGE_(1). Before and after treatment,the alterations of clinical symptoms, ankle/ brachial index (ABI), nail fold microcirculation of left ring finger were observed and compared. Results:After treatment,the nail fold microcirculation total scores were significantly decreased(P<0.01)and each item^(’)s score was decreased,too(P<0.05).Furthermore, total score was negatively correlative with ABI. Conclusion:The nail fold microcirculation examination has a good practical value in assessing clinical effect in the aged patients with LEASD.
出处 《军医进修学院学报》 CAS 北大核心 2005年第3期196-197,共2页 Academic Journal of Pla Postgraduate Medical School
关键词 动脉硬化 闭塞性 老年人 前列地尔 甲襞微循环 前列腺素E1 下肢 微循环障碍 microcirculation atherosclerosis obliterans aged alprostadil
  • 相关文献

参考文献5

二级参考文献12

  • 1[1]Jeffery I John Byrne. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review [J]. Circulation.1996,94: 3026-3049.
  • 2[2]Malinow MR, Kang SS Taylor LM Jr, et al. Prevalence of hyperhomocysteinemia in patients with peripheral arterial disease[J]. Circulation, 1989, 79: 1180-1188.
  • 3[3]Lloyd M Taylor Jr, Gregory L Moneta, Gary J Sexton, et al.Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease[J]. J Vasc Surg, 1999,29:8-21.
  • 4[4]Harris LM, Armstrong D.Premature peripheral vascular disease: clinical profile and abnormal lipid peroxidation[J]. Cardiovasc Surg,1998, 6(2): 188-193.
  • 5[5]O′Neal DN,Lewicki J.Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects[J]. Atherosclerosis,1998, 136(1): 1-8.
  • 6[6]Graham IM,Daly LE. Plasma homocysteine as a risk factor for vascular disease[J]. JAMA, 1997, 277: 1775-1781.
  • 7[7]Melton LJ,Macken KM. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients[J]. Diabetes Care, 1980,3: 650-654.
  • 8[8]Kannel WB,McGhee DL. Update on some epidemiological features of intermittent claudication: the Framingham study[J]. J Am Geriatr Soc, 1984,33: 13-18.
  • 9Stoffers HE, Rinkens PE, Kester AD, et al. The prevalence of asymptomalic and unrecognized peripheral agerial occlusive disease[J]. Int J Epidemiol, 1996,25(2) :282.
  • 10Toyota T, Hirata Y, Ikeda Y, et al. Lipo-PF1,a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin F1-controlled mulficenter trials in patients with diabetic Neuro pathy and leg ulcers[J]. Prostaglandins, 1993,46(5) :453.

共引文献13

同被引文献34

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部